Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filters

PublicationDisease areaApplication areaSample typeProducts

The Journal of Clinical Endocrinology & Metabolism, 2025
Multiomics of Human Obesity and Related Multisystem Diseases

Anwar M., Highland H., Sheng Q. et al.

Olink Explore 3072/384Metabolic DiseasesPathophysiologyPlasma

Journal of Cardiovascular Translational Research, 2025
CCL17 as an Inflammatory Biomarker Enhances Cardiovascular Risk Stratification: a Prospective Cohort Study

Wang Z., Ren X., Lu Y. et al.

Olink Explore 3072/384CVDPatient StratificationPlasma

Clinical Immunology, 2025
Glial-derived neurotrophic factor promotes aberrant basal cell hyperplasia in nasal polyps

Hou Y., Sun L., Su M. et al.

Olink Target 96Respiratory DiseasesPatient StratificationNasal Fluid

iScience, 2025
Interleukin-38 is a Negative Regulator of Trained Immunity – a Retrospective Multi-omics Study

Teufel L., Matzaraki V., Folkman L. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

Signal Transduction and Targeted Therapy, 2025
Ultra-high dose rate radiotherapy overcomes radioresistance in head and neck squamous cell carcinoma

Li H., Tang R., Shi H. et al.

Olink Target 48 MouseOncologyPathophysiologyMouse Plasma

MedComm, 2025
Efficacy, Safety, and Biomarkers of Neoadjuvant Dalpiciclib (CDK4/6 inhibitor) plus Aromatase Inhibitors in Operable HER2‐Negative Luminal B Breast Cancer: A Prospective, Single‐Center, Single‐Arm, Phase II Trial (DANCER)

Zhou Y., Zhang Z., Chen H. et al.

Olink Target 96OncologyPathophysiologyPlasma

BMC Medicine, 2025
Efficacy, safety, and exploratory biomarker analysis of envafolimab plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer: a prospective, single-arm, phase II trial

Zhao X., Zhang J., Qiu L. et al.

Olink Target 48OncologyImmunotherapyPatient StratificationSerum

Stroke, 2025
Proteome-Wide Genetic Study in East Asians and Europeans Identified Multiple Therapeutic Targets for Ischemic Stroke

Yao P., Mazidi M., Pozarickij A. et al.

Olink Explore 3072/384NeurologyPathophysiologyPlasma

Journal of Inflammation Research, 2025
Genetic Association and Drug Target Exploration Between Inflammation-Related Proteins and the Risk of Primary Ovarian Insufficiency

Wang C., Lin X., Yang X.

Olink Target 96GynecologyPathophysiologyPlasma

Allergy, 2025
Nasopharyngeal Microbiome‐Epigenome‐Wide Association Analysis in Infants With Severe Bronchiolitis

Shibata R., Li Y., Yaskolka Meir A. et al.

Olink Target 96Respiratory DiseasesImmunological & Inflammatory DiseasesPathophysiologySerum

BMC Medicine, 2025
Association between pro-inflammatory proteins and neurofilament in plasma from persons with epilepsy

Sarangdhar M., Akel S., Hosseini Ashtiani S. et al.

Olink Explore 3072/384NeurologyPathophysiologyPatient StratificationPlasma

Journal of Cardiovascular Translational Research, 2025
Plasma Proteomics for Predicting Cardiovascular Disease: How Many Proteins are Enough?

Royer P., Björnson E., Adiels M. et al.

Olink Explore 3072/384Wider Proteomics StudiesCVDData SciencePlasma

Scientific Reports, 2025
Associations of the intestinal microbiota with plasma bile acids and inflammation markers in Crohn’s disease and ulcerative colitis

Prast-Nielsen S., Granström A., Kiasat A. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

Neurosurgical Review, 2025
Potential drug targets for intracranial aneurysms identified through Mendelian randomization analysis

Peng L., Peng H., Wu N. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

BMC Nephrology, 2025
Association of Osteopontin and selective glomerular hypofiltration syndrome with hospitalization for kidney failure in acute heart failure patients

Ohlsson M., Nilsson C., Molvin J. et al.

Olink Target 96NephrologyPatient StratificationPlasma

Critical Care Explorations, 2025
Aging and Host Responses to Severe Infection: Proteomic Analysis of a Prospective Multicenter Cohort From Uganda

Conte Cortez Martins G., Lutwama J., Owor N. et al.

Olink Target 96Infectious DiseasesAgingPathophysiologySerum

Cancer Immunology, Immunotherapy, 2025
Comprehensive proteomic and pathological profiling identifies PRAS40 as a novel biomarker and mediator of primary immune checkpoint blockade resistance in non-small cell lung cancer

Mao N., He C., Kuang J. et al.

Olink Explore 3072/384OncologyImmunotherapyPatient StratificationPlasma

Journal of Affective Disorders, 2025
A novel potential biomarker panel to diagnose depression derived from big proteomic data

Ma S., Tan H., Zhang M. et al.

Olink Explore 3072/384NeurologyPatient StratificationPlasma

Circulation: Heart Failure, 2025
Plasma Proteome Analysis Identifies Vascular Endothelial Growth Factor Receptor 1 as a Prognostic Biomarker in Cardiogenic Shock

Jung C., Lang A., Duse D. et al.

Olink Explore 3072/384CVDPatient StratificationPlasma

Current Medicinal Chemistry, 2025
Mediating Effects of Plasma Metabolites in Inflammatory Protein-Lymphoma Causality: A Mendelian Randomization Study

Ji Y., Gao X., Liu L. et al.

Olink Target 96OncologyPathophysiologyPlasma

3195 publications